Viewing Study NCT00482261


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2026-01-10 @ 11:43 AM
Study NCT ID: NCT00482261
Status: COMPLETED
Last Update Posted: 2024-11-08
First Post: 2007-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module